Innocan Pharma (INNPF) Income from Continuing Operations (2024 - 2025)
Innocan Pharma (INNPF) reported Income from Continuing Operations of $1.86 million for the quarter ended Dec 31, 2025, compared with -$48,000 a year earlier.
Powered by 
Analysis
Innocan Pharma (INNPF) Income from Continuing Operations (2024 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Innocan Pharma posted Income from Continuing Operations of -$341,000.
- By year, Income from Continuing Operations came in at -$262,000 in the year ended Dec 31, 2024 and -$4.25 million in the year ended Dec 31, 2023.
- The figure for the quarter ended Dec 31, 2025 ranks as the highest quarterly Income from Continuing Operations in data going back to the quarter ended Mar 31, 2024.
- Per Business Quant data, the three quarters before the quarter ended Dec 31, 2025 came in at -$1.65 million (quarter ended Sep 30, 2025), -$315,000 (quarter ended Jun 30, 2025) and -$229,000 (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Innocan Pharma | 5.78 Mn | 1.73 Mn | 4.43 Mn | 1.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.86 Mn |
| Sep 30, 2025 | -1.65 Mn |
| Jun 30, 2025 | -315,000.00 |
| Mar 31, 2025 | -229,000.00 |
| Dec 31, 2024 | -48,000.00 |
| Sep 30, 2024 | 284,000.00 |
| Jun 30, 2024 | 956,000.00 |
| Mar 31, 2024 | -1.45 Mn |
API Access
Innocan Pharma Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=INNPF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "INNPF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=INNPF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();